1.Date of the shareholders' meeting resolution:2021/08/20
2.Name and title of the managerial officer with permission
to engage in competitive conduct:
(1)Shan Ney Huang：Representative of Kingbird Tech Co., Ltd.
(2)Kao Chung Tsai：Independent director
(3)Li Chun Han：Independent director
3.Items of competitive conduct in which the officer is
permitted to engage:
(1)Shan Ney Huang
Harmony Organic Agriculture Foundation/Chairman
Oneness Biotech Co., Ltd./Chairman and President
Cotton Field Organic Co., Ltd./Juristic-person chairman and President
(2)Kao Chung Tsai
Holy Stone Healthcare Co., Ltd./Independent director
(3)Li Chun Han
StemCyte International, Ltd./Independent director
Sinew Pharma Co. Ltd/Independent Director
4.Period of permission to engage in the competitive conduct:
Within period of serving as directors of Company.
5.Circumstances of the resolution (please describe the
results of voting in accordance with Article 209 of the
The total attended voting shares by shareholders:289,667,233; the approval
votes:288,367,652; the disapproval votes:319,979; the invalid votes:0; the
abstention votes:979,602; The approval votes was 99.55% of the total
attended voting shares.The proposal was therefore approved.
meeting attended by shareholders.
6.If the permitted competitive conduct belongs to the
operator of a mainland China enterprise, the name and
title of the directors (if it is not the operator of
a mainland China enterprise, please enter “N/A” below):N/A
7.Company name of the mainland China enterprise and the
officer’s position in the enterprise:N/A
8.Address of the mainland China enterprise:N/A
9.Operations of the mainland China enterprise:N/A
10.Impact on the company’s finance and business:
(1)Oneness Biotech Co., Ltd. is invested by the company and its profits or
losses is recognized by equity method.
(2)Cotton Field Organic Co.,Ltd. is a subsidiary of the company and its
profits or losses is recognized by equity method.
11.If the directors have invested in the mainland China
enterprise, the monetary amount of the investment and
their shareholding ratio:N/A
12.Any other matters that need to be specified:None